Macimorelin acetate (Ghryvelin®). HTA ID: 22062

Assessment Status Rapid Review Complete
HTA ID 22062
Drug Macimorelin acetate
Brand Ghryvelin®
Indication For the diagnosis of growth hormone deficiency (GHD) in adults.
Assessment Process
Rapid review commissioned 30/08/2022
Rapid review completed 04/10/2022
Rapid review outcome The NCPE recommends that macimorelin acetate (Ghryvelin®) not be considered for reimbursement at the submitted price*.

*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.